Johnson & Johnson has issued another recall, and this time, it's not over a typo. The company's Animas unit recalled five lots of leaking insulin cartridges whose use could lead to serious health problems. The 2-milliliter cartridges can leak, resulting in the delivery of less insulin than intended.
Diabetes is a growing global scourge, but for Big Pharma it's more of a lifesaver -- and many drugmakers are cranking up their research efforts. After all, many existing drugs will soon be losing their patents, and diabetes could be a $55 billion market by 2019.
Pharmaceutical giant Eli Lilly -- maker of Prozac and Cialis -- is expected to post solid fourth-quarter profits on Thursday after a recent restructuring. But the results will likely be lower than the year-ago quarter.
